These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
80 related articles for article (PubMed ID: 23324271)
21. Increased expression of osteopontin in patients with triple-negative breast cancer. Wang X; Chao L; Ma G; Chen L; Tian B; Zang Y; Sun J Eur J Clin Invest; 2008 Jun; 38(6):438-46. PubMed ID: 18452545 [TBL] [Abstract][Full Text] [Related]
22. Expression of ezrin, HGF and c-met and its clinicopathological significance in the benign and malignant lesions of the gallbladder. Yang L; Guo T; Jiang S; Yang Z Hepatogastroenterology; 2012 Sep; 59(118):1769-75. PubMed ID: 22172411 [TBL] [Abstract][Full Text] [Related]
23. Tissue microarray analysis of signal transducers and activators of transcription 3 (Stat3) and phospho-Stat3 (Tyr705) in node-negative breast cancer shows nuclear localization is associated with a better prognosis. Dolled-Filhart M; Camp RL; Kowalski DP; Smith BL; Rimm DL Clin Cancer Res; 2003 Feb; 9(2):594-600. PubMed ID: 12576423 [TBL] [Abstract][Full Text] [Related]
24. Expression of ezrin, MMP-9, and COX-2 in 50 chordoma specimens: a clinical and immunohistochemical analysis. Froehlich EV; Scheipl S; Lazàry A; Varga PP; Schmid C; Stammberger H; Beham A; Bodo K; Schroettner H; Quehenberger F; Windhager R; Liegl B; Leithner A Spine (Phila Pa 1976); 2012 Jun; 37(13):E757-67. PubMed ID: 22228328 [TBL] [Abstract][Full Text] [Related]
25. Biologic role of activated leukocyte cell adhesion molecule overexpression in breast cancer cell lines and clinical tumor tissue. Hein S; Müller V; Köhler N; Wikman H; Krenkel S; Streichert T; Schweizer M; Riethdorf S; Assmann V; Ihnen M; Beck K; Issa R; Jänicke F; Pantel K; Milde-Langosch K Breast Cancer Res Treat; 2011 Sep; 129(2):347-60. PubMed ID: 20972617 [TBL] [Abstract][Full Text] [Related]
26. Significance of cellular distribution of ezrin in pancreatic cystic neoplasms and ductal adenocarcinoma. Yeh TS; Tseng JH; Liu NJ; Chen TC; Jan YY; Chen MF Arch Surg; 2005 Dec; 140(12):1184-90. PubMed ID: 16365240 [TBL] [Abstract][Full Text] [Related]
27. The Na+-H+ exchanger-1 induces cytoskeletal changes involving reciprocal RhoA and Rac1 signaling, resulting in motility and invasion in MDA-MB-435 cells. Paradiso A; Cardone RA; Bellizzi A; Bagorda A; Guerra L; Tommasino M; Casavola V; Reshkin SJ Breast Cancer Res; 2004; 6(6):R616-28. PubMed ID: 15535843 [TBL] [Abstract][Full Text] [Related]
28. Expression of the membrane-cytoskeletal linker Ezrin in salivary gland adenoid cystic carcinoma. Wang YY; Chen WL; Huang ZQ; Yang ZH; Zhang B; Wang JG; Li HG; Li JS Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2011 Jul; 112(1):96-104. PubMed ID: 21550270 [TBL] [Abstract][Full Text] [Related]
29. Podocalyxin activates RhoA and induces actin reorganization through NHERF1 and Ezrin in MDCK cells. Schmieder S; Nagai M; Orlando RA; Takeda T; Farquhar MG J Am Soc Nephrol; 2004 Sep; 15(9):2289-98. PubMed ID: 15339978 [TBL] [Abstract][Full Text] [Related]
30. Different roles of S100P overexpression in intrahepatic cholangiocarcinoma: carcinogenesis of perihilar type and aggressive behavior of peripheral type. Aishima S; Fujita N; Mano Y; Kubo Y; Tanaka Y; Taketomi A; Shirabe K; Maehara Y; Oda Y Am J Surg Pathol; 2011 Apr; 35(4):590-8. PubMed ID: 21412073 [TBL] [Abstract][Full Text] [Related]
31. Expression of matrix metalloproteinase (MMP)-2 and MMP-9 in breast cancer with a special reference to activator protein-2, HER2, and prognosis. Pellikainen JM; Ropponen KM; Kataja VV; Kellokoski JK; Eskelinen MJ; Kosma VM Clin Cancer Res; 2004 Nov; 10(22):7621-8. PubMed ID: 15569994 [TBL] [Abstract][Full Text] [Related]
32. Roles of p-ERM and Rho-ROCK signaling in lymphocyte polarity and uropod formation. Lee JH; Katakai T; Hara T; Gonda H; Sugai M; Shimizu A J Cell Biol; 2004 Oct; 167(2):327-37. PubMed ID: 15504914 [TBL] [Abstract][Full Text] [Related]
33. Signal transducer and activator of transcription-5 activation and breast cancer prognosis. Nevalainen MT; Xie J; Torhorst J; Bubendorf L; Haas P; Kononen J; Sauter G; Rui H J Clin Oncol; 2004 Jun; 22(11):2053-60. PubMed ID: 15169792 [TBL] [Abstract][Full Text] [Related]
34. [Relationship between the expression of E-cadherin-catenins and alpha-, beta-, gamma-catenin and the metastasis and prognosis of breast cancer]. Zou W; Hu CH; Zhou JP Hunan Yi Ke Da Xue Xue Bao; 2002 Dec; 27(6):499-502. PubMed ID: 12658921 [TBL] [Abstract][Full Text] [Related]
35. Overexpression of Cripto and its prognostic significance in breast cancer: a study with long-term survival. Gong YP; Yarrow PM; Carmalt HL; Kwun SY; Kennedy CW; Lin BP; Xing PX; Gillett DJ Eur J Surg Oncol; 2007 May; 33(4):438-43. PubMed ID: 17125961 [TBL] [Abstract][Full Text] [Related]
36. The overexpression of RHAMM, a hyaluronan-binding protein that regulates ras signaling, correlates with overexpression of mitogen-activated protein kinase and is a significant parameter in breast cancer progression. Wang C; Thor AD; Moore DH; Zhao Y; Kerschmann R; Stern R; Watson PH; Turley EA Clin Cancer Res; 1998 Mar; 4(3):567-76. PubMed ID: 9533523 [TBL] [Abstract][Full Text] [Related]
38. Down-regulation of miR-183 promotes migration and invasion of osteosarcoma by targeting Ezrin. Zhu J; Feng Y; Ke Z; Yang Z; Zhou J; Huang X; Wang L Am J Pathol; 2012 Jun; 180(6):2440-51. PubMed ID: 22525461 [TBL] [Abstract][Full Text] [Related]
39. Prognostic significance of DNA image cytometry in Libyan breast cancer. Ermiah E; Abdalla F; Buhmeida A; Alshrad M; Salem N; Pyrhönen S; Collan Y Oncology; 2012; 83(3):165-76. PubMed ID: 22906963 [TBL] [Abstract][Full Text] [Related]
40. Prognostic significance of E-cadherin and ezrin immunohistochemical expression in prostate cancer. Musiał J; Sporny S; Nowicki A Pol J Pathol; 2007; 58(4):235-43. PubMed ID: 18459457 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]